UDC 619: 615.2.619: 618.19-002
DOI: 10.26155/vet.zoo.bio.202002003
Authors
Yu. S. Kruglova
Candidate of Veterinary Sciences, Associate Professor of the Department of Diagnosis of Diseases, Therapy, Obstetrics and Animal Reproduction, Moscow State Academy of Veterinary Medicine and Biotechnology - MVA named after K. I. Skryabin,
R. V. Rogov
Candidate of Biological Sciences, Associate Professor of the Department of Diagnosis of Diseases, Therapy, Obstetrics and Animal Reproduction, Moscow State Academy of Veterinary Medicine and Biotechnology - MBA named after K. I. Skryabin,
I. G. Ryazanov
Candidate of Agricultural Sciences, Associate Professor, Department of Animal Hygiene and Poultry, Moscow State Academy of Veterinary Medicine and Biotechnology - MBA named after K. I. Skryabin
Abstract
The article presents the results of clinical trials of the veterinary drug Mastinol-forte. The effectiveness of the drug in the treatment of subclinical forms of mastitis was studied. Under the conditions of an experiment on patients with a subclinical form of mastitis, lactating cows substantiated and studied the possibility of using the drug Mastinol-forte. It was found that intramuscular administration of the drug to cows with a subclinical form of mastitis for three days (once a day) at a dose of 7 ml per administration is well tolerated by animals, gives a positive clinical effect and leads to normalization of laboratory parameters of milk.
Keywords
subclinical mastitis, mastinol-forte, lactating cows, milk, somatic cells.
